Literature DB >> 1202245

Purification of influenza viral complementary RNA: its genetic content and activity in wheat germ cell-free extracts.

P R Etkind, R M Krug.   

Abstract

Influenza viral complementary RNA (cRNA) was purified free from any detectable virion-type RNA (vRNA), and its genetic content and activity in wheat germ cell-free extracts were examined. After phenol-chloroform extraction of cytoplasmic fractions from infected cells, poly(A)-containing viral cRNA is found in two forms: in single-stranded RNA and associated with vRNA in partially and fully double-stranded RNA. To purify single-stranded cRNA free of these double-stranded forms, it was necessary to employ, as starting material, RNA fractions in which cRNA was predominantly single stranded. Two RNA fractions were successfully employed as starting material: polyribosomal RNA and the total cytoplasmic RNA from infected cells treated with 100 mug of cycloheximide (CM) per ml at 3 h after infection. In WSN virus-infected canine kidney (MDCK) cells, the addition of CM at 3 h after infection stimulates the production of cRNA threefold and causes a very large increase in the proportion of the cytoplasmic cRNA which is single stranded; double-stranded RNA forms are greatly reduced in amount. Total cRNA was obtained by oligo(dT)-cellulose chromatography, and single-stranded cRNA was separated from double-stranded forms by Sepharose 4B chromatography. The cRNA preparation purified from polyribosomes consists of 95% single-stranded cRNA, with the remaining 5% apparently being double-stranded RNA forms. The cRNA preparation purified from CM-treated cells (CM cRNA) is even more pure: 100% of the radiolabeled RNA is single-stranded cRNA. Annealing experiments, in which a limited amount of 32P-labeled genome RNA was annealed to the cRNA, indicate that the purified cRNA contains at least 84 to 90% of the genetic information in the vRNA genome. Purified viral cRNA (CM cRNA) is very active in directing the synthesis of virus-specific proteins in wheat germ cell-free extracts.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1202245      PMCID: PMC355755     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis.

Authors:  R M Krug; M Ueda; P Palese
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

2.  Complementary RNAs in paramyxovirions and paramyxovirus-infected cells.

Authors:  A Portner; D W Kingsbury
Journal:  Nature       Date:  1970-12-19       Impact factor: 49.962

3.  Self-annealing of subgroup 2 myxovirus RNAs.

Authors:  W S Robinson
Journal:  Nature       Date:  1970-03-07       Impact factor: 49.962

4.  Structure of the poliovirus replicative intermediate RNA.

Authors:  D Baltimore
Journal:  J Mol Biol       Date:  1968-03-14       Impact factor: 5.469

5.  Influenza viral messenger RNA.

Authors:  P R Etkind; R M Krug
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

6.  Evidence that all messenger RNA molecules (except histone messenger RNA) contain Poly (A) sequences and that the Poly(A) has a nuclear function.

Authors:  M Adesnik; M Salditt; W Thomas; J E Darnell
Journal:  J Mol Biol       Date:  1972-10-28       Impact factor: 5.469

7.  Identification of the in vitro translation products of adenovirus mRNA by immunoprecipitation.

Authors:  B Oberg; J Saborio; T Persson; E Everitt; L Philipson
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

8.  Complementary RNA species isolated from vesicular stomatitis (HR strain) defective virions.

Authors:  P Roy; P Repik; E Hefti; D H Bishop
Journal:  J Virol       Date:  1973-06       Impact factor: 5.103

9.  Transcription of the influenza ribonucleic acid genome by a virion polymerase. I. Optimal conditions for in vitro activity of the ribonucleic acid-dependent ribonucleic acid polymerase.

Authors:  D H Bishop; J F Obijeski; R W Simpson
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

10.  Characterization of the subunit structure of the ribonucleic acid genome of influenza virus.

Authors:  L J Lewandowski; J Content; S H Leppla
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

View more
  34 in total

1.  Influenza viral mRNA contains internal N6-methyladenosine and 5'-terminal 7-methylguanosine in cap structures.

Authors:  R M Krug; M A Morgan; A J Shatkin
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

2.  Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells.

Authors:  T G Lee; J Tomita; A G Hovanessian; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Message activity of influenza viral RNA.

Authors:  P Tekamp; E E Penhoet
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

4.  Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs.

Authors:  M G Katze; B M Detjen; B Safer; R M Krug
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

5.  Segments of influenza virus complementary RNA synthesized in vitro.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

6.  The alpha/beta interferon receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling.

Authors:  Alan G Goodman; Hui Zeng; Sean C Proll; Xinxia Peng; Cristian Cillóniz; Victoria S Carter; Marcus J Korth; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

7.  Nucleotide sequence of influenza virus RNA segment 8 indicates that coding regions for NS1 and NS2 proteins overlap.

Authors:  A G Porter; J C Smith; J S Emtage
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Preparation of projection-less particles from influenza virus and their messenger activities in prokaryotic and eukaryotic systems.

Authors:  E N Arida; T Hultin
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

9.  Use of specific radioactive probes to study transcription and replication of the influenza virus genome.

Authors:  J M Taylor; R Illmensee; S Litwin; L Herring; B Broni; R M Krug
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

10.  Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.